| 000 | 01798 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516014108.0 | ||
| 264 | 0 | _c20110617 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-10-1731 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBagatell, R | |
| 245 | 0 | 0 |
_aPharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cFeb 2011 |
||
| 300 |
_a611-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacokinetics |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aHerzog, C E | |
| 700 | 1 | _aTrippett, T M | |
| 700 | 1 | _aGrippo, J F | |
| 700 | 1 | _aCirrincione-Dall, G | |
| 700 | 1 | _aFox, E | |
| 700 | 1 | _aMacy, M | |
| 700 | 1 | _aBish, J | |
| 700 | 1 | _aWhitcomb, P | |
| 700 | 1 | _aAikin, A | |
| 700 | 1 | _aWright, G | |
| 700 | 1 | _aYurasov, S | |
| 700 | 1 | _aBalis, F M | |
| 700 | 1 | _aGore, L | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 17 _gno. 3 _gp. 611-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-10-1731 _zAvailable from publisher's website |
| 999 |
_c20418726 _d20418726 |
||